Cargando…
Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction
Commonly used drugs for treating many conditions are either natural products or derivatives. In silico modelling has identified several natural products including quercetin as potential highly effective disruptors of the initial infection process involving binding to the interface between the SARS-C...
Autores principales: | Williamson, Gary, Kerimi, Asimina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316054/ https://www.ncbi.nlm.nih.gov/pubmed/32593613 http://dx.doi.org/10.1016/j.bcp.2020.114123 |
Ejemplares similares
-
The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022) -
Structural Dissection of Viral Spike-Protein Binding of SARS-CoV-2 and SARS-CoV-1 to the Human Angiotensin-Converting Enzyme 2 (ACE2) as Cellular Receptor
por: Giordano, Deborah, et al.
Publicado: (2021) -
Synthetic Peptides
That Antagonize the Angiotensin-Converting
Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor
Binding Spike Protein
por: Sadremomtaz, Afsaneh, et al.
Publicado: (2021) -
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
por: Bian, Jingwei, et al.
Publicado: (2021) -
SARS-CoV-2, the Angiotensin Converting Enzyme 2 (ACE2) Receptor and Alzheimer’s disease
por: Lukiw, Walter J.
Publicado: (2021)